EAST WINDSOR, N.J. — Aurobindo Pharma USA (Aurobindo) has proposed the acquisition of Lannett Co. (Lannett). The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
"Over the coming months, we will be providing additional updates on this exciting acquisition and how we expect it to enable us to better serve you, our valued customer," said Paul McMahon, president, APUSA Oral Solids Division at Aurobindo. "In the meantime, until the transaction closes, it will be business as usual in every respect with both Aurobindo and Lannett continuing to operate as separate entities. Please continue to work with your respective points of contact at Aurobindo and Lannett for any of your normal day-to-day business needs regarding the respective product portfolios, operational and transactional matters, etc," he added.
Aurobindo to purchase Lannett Co.
The company says it anticipates closing the acquisition towards the middle of calendar 2026, subject to regulatory approval.
Latest
retailmediaIQ Rx Roundtable brings industry leaders together
retailmediaIQ’s annual pharmacy roundtable brought together retail and supplier executives to examine critical issues facing community pharmacy.
retailmediaIQ hosts breakfast meeting at NACDS TSE
During a retailmediaIQ breakfast at NACDS Total Store Expo, regional retail executives emphasized local market knowledge, adaptability, and supplier partnerships as key advantages.
Estée Lauder brings science to shade matching
The collaboration could help the company improve shade accuracy, develop more natural, consistent formulas, and enhance inclusivity across its luxury beauty portfolio.
CRN initiative expands nutrition access in Missouri
Stratum Nutrition is contributing 10,000 bottles of multivitamins through Vitaquest’s VQ Cares program.